Vietnamese crab exporter

Science behind Zydus Cadila vaccine: Using plasmid DNA platform to fight Covid-19

ZyCoV-D is a plasmid DNA vaccine which, when injected, produces the spike protein to elicit an immune response.

Advertisement
Science behind Zydus Cadila vaccine: Using plasmid DNA platform to fight Covid-19
The Company has also evaluated a two dose regimen for ZyCoV-D vaccine.

Zydus Cadila on Thursday applied for emergency use authorisation for its Covid-19 vaccine. The company has approached the Drug Controller General of India (DCGI) for a nod to its ZyCoV-D — Plasmid DNA vaccine.

The company conducted the largest clinical trial in India at over 50 centres. A clinical trial was also conducted among the adolescent population in the 12-18 years age group for which the company enrolled 1,000 participants and reported the vaccine to be safe.

advertisement

“This breakthrough marks a key milestone in scientific innovation and advancement in technology. As the first-ever plasmid DNA vaccine for human use, ZyCoV-D has proven its safety and efficacy profile in our fight against COVID-19. The vaccine, when approved, will help not only adults but also adolescents in the 12 to 18 years age group," Dr Sharvil Patel, MD, Cadila Healthcare, said.

Also Read: Science behind Moderna vaccine: Triggering immune response against Covid-19 using mRNA

How was the Zydus Cadila vaccine designed?

ZyCoV-D is a plasmid DNA vaccine which, when injected, produces the spike protein similar to those studded on the surface of coronavirus. The spike proteins elicit a response mediated by the cellular and humoral arms of the human immune system, which play a vital role in protection from disease as well as viral clearance.

The plug and play technology on which the plasmid DNA platform is based is ideally suited for dealing with COVID-19 as it can be easily adapted to deal with mutations in the virus, such as those already occurring.

ALSO READ: Johnson & Johnson Covid vaccine likely to be available in India by July

ZyCoV-D is a three-dose, intradermal vaccine, applied using the needle-free system, Tropis, which can also lead to a significant reduction in any kind of side effects. However, the company has also announced a two-dose regimen for the vaccine.

Efficacy of the vaccine

The company has said that its vaccine showed a robust efficacy and safety profile in Phase I, II trials, which were observed by an independent Data Safety Monitoring Board (DSMB). Meanwhile, among teens, the tolerability profile was similar to that seen in the adult population. Primary efficacy of 66.6 per cent was attained for symptomatic RT-PCR positive cases in the interim analysis. The company has said that the Phase I data is in the pre-print and they are working on the Phase III data, which will be published in 4-6 months.

Also Read: Science behind Novavax vaccine and how it could boost vaccination in middle & low-income countries

What differentiates ZyCoV-D vaccine?

advertisement

The ZyCoV-D is a three-dose, intradermal vaccine, which leads to a significant reduction in any kind of side effects. The vaccine is stored at 2-8 degrees Celsius but has shown good stability at temperatures of 25 degrees Celsius for at least three months. The thermostability of the vaccine will help in easy transportation, storage and reduce any cold chain breakdown challenges leading to vaccine wastage.

The plasmid DNA platform provides ease of manufacturing with minimal biosafety requirements (BSL-1). Also, being a plasmid DNA vaccine, ZyCoV-D does not have any problem associated with vector-based immunity. The Plasmid DNA platform also allows generating new constructs quickly to deal with mutations in the virus.

Gopi Maniar Ghanghar

Gopi Maniar Ghanghar, Deputy Editor AAJTAK Gujarat Bureau, she looks after the entire Gujarat and associated with AAJTAK & India Today group since 2002. She is Editor of Gujarat Tak a digital plat form of TVToday Group, she successfully run it and shown her vast knowledge of regional politics & cultural in Gujart tak. she heads a team of journalist to get best output for Gujarat. She is contributing in TV Today network's all Digital platform.

Her vast experience in Gujarat Politics and catching the pulse of Gujarat is unparallel in present time. She started her reporting carrier from 2001 Gujarat earth quake and covered 2002 riots. She has witness the journey of Gujarat politics transfer of power from Keshubhai to Narendra Modi, and from three terms of Chief Minister Narendra Modi. Also huge transformation from Narendra Modi's Hinduva to Narendra Modi's vikas agenda, from CM to PM, and rise of power of Mr.Narendra Modi and BJP.

Fake encounter stories covered by her became most popular. It was like a milestone in the industry and created a huge wave in Journalism as well as political circle. Amit shah's court case being fugitive from Gujarat taking asylum in centre and rising back with more strength and power responsibility in his own party. She has witnessed all this events as frame by frame throughout her carrier as journalist. Also, the transformation of Amit Shah from state politics to nation politics. state MoS to HM of the country.

In a religious country like India , where god mans are treated very next to the God, they have never been questioned. Hence, they think they are above the law of land. Her constant thrives for truth in 2008s Dipesh Abhishek Murder case of Asharam Asaram concluded the God man found guilty and was questioned for the first time and it resulted in his severing in Jail. While reporting this case she stood firm against the goon of God Man Asaram, even though she was brutally beaten in the process of covering the truth and leading the story ahead to it's final judgment. This is the impact of Gold standard Journalism.

Gopi Maniar Ghanghar Born in Ahmedabad Gujarat, she studied in St. Xavier's collage Ahmedabad and did her Masters in Journalism and Mass Communication from Gandhian institute Gujarat Vidhyapith. She was awarded twice with INDIA TODAY CHAIRMAN's award for best coverage for Gujarat Election in 2017 and web stories for 2018 and many others award from Gujarat as well.

READ MORE